Clinical Trial Update: A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate odronextamab versus rituximab with chemotherapy in adults with previously untreated follicular lymphoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Odronextamab (odronextamab)
• Rituximab (rituximab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Follicular Lymphoma (FL) | Phase 3 | Status: RECRUITING